Recent Articles from Investor Brand Network

A new preclinical investigation from the University of California, Riverside, is offering fresh insight into a puzzling trend researchers have observed for years: people who regularly use cannabis often show lower body weight and a smaller likelihood of developing type 2 diabetes, even though marijuana is widely known to stimulate hunger.

Frontieras is positioned as global energy systems are under increasing strain as industrial demand accelerates and reliable baseload power becomes more critical to economic stability. The company “is developing a breakthrough energy-processing technology known as FASForm(TM) that deconstructs coal and other solid hydrocarbons into multiple high-value fuels and industrial products, redefining the utility and economics of coal without burning it,” reads a recent article. “By unlocking the hidden components of coal through a patented Solid Carbon Fractionation process, the company is focused on delivering abundant, affordable, available energy solutions, and a new generation of diverse industrial revenue streams, from a resource long dismissed as outdated.”

Perpetuals.com’s (NASDAQ: PDC) CEO Patrick Gruhn outlined the company’s strategy and AI-driven trading infrastructure at a recent Emerging Growth Conference. An article discussing this reads, “Perpetuals’ platform has also been designed to comply with European regulatory regimes, including MiFID II, MiCA, DORA, and EMIR. The regulatory positioning reflects a broader structural shift within digital asset markets. While demand for leveraged crypto exposure continues to expand, many traditional brokers and financial institutions face regulatory barriers that limit their ability to connect with offshore trading venues.”

Greenland Energy (NASDAQ: GLND) is advancing a large-scale frontier oil exploration opportunity in East Greenland’s Jameson Land Basin, where it holds rights to up to a 70% working interest across more than 2 million acres. The basin, originally evaluated by ARCO but never drilled, has been estimated by independent engineering firm Sproule ERCE to contain upside potential of 13 billion recoverable barrels of oil. Following its March 2026 Nasdaq debut, Greenland Energy has moved toward operational execution by securing Arctic-rated rig services from Stampede Drilling along with agreements involving Halliburton, Desgagnés, and IPT Well Solutions to support its planned 2026 drilling campaign. With infrastructure mobilization underway and growing strategic interest in Arctic energy security, the company is positioning itself to test one of the largest undrilled onshore hydrocarbon basins.

American farmers are facing a brutal combination of erratic weather, climbing input costs, and margins so thin that one bad season can erase a year’s profit. New RMI research shows wind and solar income rivaling major farm commodities in some states, a development with real implications for cash-strapped farming communities.

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising.

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising.

Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising.

Cardio Diagnostics Holdings (NASDAQ: CDIO), a precision medicine company leveraging epigenetics, genetics and artificial intelligence, is poised to meet demands as cardiovascular disease continues to place a profound burden on individuals, economies and healthcare systems worldwide. “Cardio Diagnostics is committed to reducing the impact of heart disease by developing a platform that integrates artificial intelligence and epigenetic and genetic biomarkers to deliver personalized cardiovascular insights from a simple blood sample, positioning itself at the intersection of precision medicine and preventive care,” reads a recent article.

The Blockchain Futurist Conference is set to return to Toronto on July 21-22, taking the spotlight at its flagship venue, Rebel Entertainment Complex and Cabana Pool Bar. The ninth edition conference, part of Emerald Expositions’ global portfolio, is expanding its international reach while continuing to focus on high-value networking and business development for founders, executives, investors, policymakers, and innovators. Known for its unconventional indoor-outdoor venue and VIP waterfront cabanas, Futurist structures its events and experiences to maximize high-value connections and real deal-making. The 2026 event will delve into hot topics such as Web3 and AI convergence, stablecoins, RWAs, and institutional adoption. As Canada’s longest-running Web3 event, Blockchain Futurist Conference remains a central platform for exploring the technologies shaping the future of finance and digital innovation.

Crypto asset investment products attracted almost $860 million in fresh capital last week, marking the sixth straight week of positive flows as optimism surrounding proposed U.S. regulation continued to influence market sentiment.

As major technology companies pour billions into AI, two of the sector’s biggest names are increasingly turning to overseas debt markets to support rising costs tied to the fast-moving AI race.

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising.

Most people are aware that cardiovascular disease (“CVD”) is the leading cause of death in the United States; what they might not know is that an estimated 80% of those cases are considered preventable through earlier detection and proactive management of key risk factors. This highlights the urgent need for more effective tools that can identify risk earlier and guide personalized intervention strategies. Cardio Diagnostics Holdings (NASDAQ: CDIO) is rising to the challenge by developing a suite of clinical, population health and biopharma solutions designed to leverage artificial intelligence (“AI”), epigenetics and genetics to improve cardiovascular disease prevention, detection and management.

A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) reported first-quarter 2026 results reflecting continued transition from pilot programs to scaled commercial deployment, with contracted backlog expanding to approximately $195 million representing more than 19,000 smart carts scheduled for deployment through 2027. The company also highlighted growing retail media monetization, approximately 2,500 cumulative smart cart deliveries, expanded manufacturing and international support infrastructure, and recently secured approval for a $30 million non-dilutive contract-backed credit facility to support continued growth.

Oncotelic Therapeutics (OTCQB: OTLC) was featured in a NetworkNewsAudio audio press release focused on emerging opportunities in central nervous system drug delivery, highlighting the challenges posed by the blood-brain barrier and the company’s efforts to advance technologies designed to overcome those limitations. The editorial also noted Oncotelic’s recent strategic monetization agreement with Lunai Bioworks involving its N2B delivery system, supporting initiatives in biodefense and Alzheimer’s disease treatment.

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising.

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising.

Global demand for energy is accelerating at a historic pace as artificial intelligence (“AI”), advanced manufacturing and industrial expansion place increasing pressure on existing power systems. Governments and industries are exploring nearly every available energy source to meet that demand, yet one of the world’s most abundant and energy-dense resources remains widely overlooked and underutilized.

This article has been disseminated on behalf of SureNano Science Ltd. and may include paid advertising.

This article has been disseminated on behalf of Trilogy Metals Inc. and may include paid advertising.

Oncotelic Therapeutics (OTCQB: OTLC) reported first-quarter 2026 financial results and a corporate update highlighting continued advancement across its oncology, AI-enabled drug development and advanced drug delivery initiatives, including progress within its Sapu Nano joint venture and nose-to-brain CNS delivery platform. The company also said it maintained the previously established approximately $388 million fair value of its 45% ownership interest in GMP Biotechnology as of March 31, 2026, while continuing to pursue capital-efficient growth across its diversified biotechnology platform.

This article has been disseminated on behalf of McEwen Inc. and may include paid advertising.

Safe Pro Group (NASDAQ: SPAI) reported record first-quarter 2026 revenue of $1.22 million, a 560% increase from the prior-year period, driven by commercialization of its AI-powered edge computing and drone imagery analysis solutions for defense applications. The company also reported gross margins exceeding 68%, a cash balance of $14.8 million, expanded government-focused leadership, and growing traction for its NODE, NODE-X and SPOTD AI platforms supporting battlefield situational awareness and explosive threat detection.

Seasonal influenza often spreads rapidly, and timely data can help policymakers and the health care system make the right decisions on matters like resource planning. A new study conducted in Japan suggests that monitoring wastewater could be a helpful way of learning in advance how influenza outbreaks are likely to manifest a week before data on patients affected flag outbreak trends.

Scientists have introduced a newly engineered catalyst that may significantly reduce the cost of hydrogen production, improving the practicality of renewable energy storage systems. Hydrogen is widely regarded as a clean energy source because it can store renewable electricity and generates no carbon emissions when used.

After over a decade of actively avoiding the growing battery electric vehicle sector, Japan is finally making forays into BEV production to deal with the threat posed by China’s behemoth EV industry. Toyota was one of the very first automakers to produce an alternative energy vehicle, the Prius, but the Japanese automaker stuck with the infamous hybrid over fully electric cars while other automakers were investing billions of dollars into BEV production.

Europe’s startup ecosystem is increasingly being shaped by AI, with new figures showing that AI-focused companies accounted for a substantial share of venture investment across the region in 2026. According to Crunchbase data, close to half of all venture capital deployed in Europe so far this year has flowed into businesses connected to artificial intelligence.

Annovis Bio (NYSE: ANVS) reported first-quarter 2026 business and financial results, highlighting continued advancement of its clinical-stage neurodegenerative disease programs, including 85% enrollment in its pivotal Phase 3 Alzheimer’s disease trial and closure of enrollment to new participants after reaching sufficient screening levels to meet enrollment goals.

The release of the long-awaited CLARITY Act has intensified debate in Washington over how the U.S. should regulate digital assets. Shortly after midnight on Tuesday, May 11, the Senate Banking Committee published the bill’s full 309-page text ahead of a key hearing scheduled for Thursday.

On Wednesday, shares of Ford Motor jumped 13%, a stock movement that was its best daily performance in nearly half a decade. This jump came as the company announced that it was venturing into energy storage as a way to utilize the factory space that had previously been allocated to making EV batteries.

China’s electric vehicle industry is now facing growing pressure from Western countries, especially Europe and the United States. Many analysts are comparing this situation to what happened to Japan’s car industry in the 1980s, when American leaders restricted Japanese car exports to protect local automakers. At that time, companies like Toyota, Honda, and Nissan were rapidly expanding across the world and taking a large share of the U.S. market.

NanoViricides, Inc. (NYSE American: NNVC) announced the filing of its quarterly report for the period ended March 31, 2026, highlighting continued advancement of its broad-spectrum antiviral candidate NV-387 toward Phase II clinical development for MPox in the Democratic Republic of Congo, where regulatory approval for the trial has already been obtained. The company also outlined progress in its orphan-first regulatory strategy, including FDA orphan drug designation for measles granted subsequent to the quarter and additional applications targeting MPox and smallpox.

NanoViricides, Inc. (NYSE American: NNVC) announced a securities purchase agreement with a single institutional investor for a registered direct offering expected to generate approximately $2 million in gross proceeds through the sale of 1,333,334 common shares, or pre-funded warrants in lieu thereof, along with accompanying warrants to purchase an equal number of common shares. The accompanying warrants will carry an exercise price of $1.75 per share and a three-year term, with closing expected on or about May 18, 2026, subject to customary conditions.

SOLOWIN HOLDINGS (NASDAQ: AXG) announced that its AX Coin stablecoin subsidiary has signed a non-binding memorandum of understanding with INFINIOS to develop regulated wallet infrastructure and digital payment solutions aimed at accelerating stablecoin adoption across the Gulf region. The collaboration is expected to integrate AX Coin into INFINIOS’ payments infrastructure, enabling compliant custodial and non-custodial wallet solutions, multi-currency virtual accounts, fiat on/off ramps, and real-time cross-border settlement capabilities for institutional clients.

LIXTE Biotechnology Holdings (NASDAQ: LIXT), announced the filing of its first-quarter 2026 Form 10-Q, highlighting continued advancement of its lead oncology candidate, LB-100, including expansion of its ovarian cancer trial following favorable safety findings in combination with immunotherapy. The company also cited continued growth at its recently acquired Liora Technologies Europe subsidiary as it pursues broader strategic expansion to strengthen its oncology pipeline and treatment development capabilities.

Nutriband (NASDAQ: NTRB) announced that its wholly owned subsidiary, Active Intelligence, will participate in the June 2026 ECRM conference, where it plans to showcase its expanding portfolio of wellness, recovery and performance-focused consumer products to buyers from major retail, pharmacy and healthcare organizations. The company will feature its existing AI Tape line and introduce new products including AI Performance Tape, AI Energy Patches and AI Sleep as it seeks to expand retail partnerships and distribution opportunities.

Forward Industries (NASDAQ: FWDI) reported fiscal second-quarter 2026 results, highlighting strategic actions to strengthen its balance sheet and expand its Solana-focused treasury strategy, including a $40 million institutional debt facility with Galaxy Digital, a $27.4 million share repurchase that reduced basic shares outstanding by 7.4%, and implementation of a cost reduction plan expected to lower quarterly SG&A expenses. The company also announced a strategic investment in OnRe and plans to deploy up to $25 million into its yield-bearing token, expanding exposure to tokenized real-world assets while diversifying revenue streams beyond its core SOL-focused strategy.

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.

Lantern Pharma (NASDAQ: LTRN) announced the closing of its previously announced registered direct offering, raising approximately $4.4 million in gross proceeds through the sale of 2,135,923 shares of common stock, or pre-funded warrants in lieu thereof, at $2.06 per share. In a concurrent private placement, the company also issued unregistered warrants to purchase up to 2,135,923 additional shares at an exercise price of $2.27 per share, which could generate up to approximately $4.85 million in additional gross proceeds if fully exercised.

Datavault AI (NASDAQ: DVLT) reported first-quarter 2026 revenue of $3.4 million, a 443% increase from $0.6 million in the prior-year period, driven primarily by the acquisition of CompuSystems, while reiterating its full-year revenue target of at least $200 million.

Beeline Holdings (NASDAQ: BLNE) reported first-quarter 2026 net revenue of $2.7 million, more than doubling from the prior-year period, driven by loan originations of $85.6 million across 288 loans compared with $39.8 million across 128 loans a year earlier. The company reported a net loss of $5.3 million, improved from $6.9 million in the prior-year quarter, while adjusted EBITDA loss narrowed to $3.0 million from $3.8 million, as Beeline continued expanding its capital-light BeelineEquity platform and reiterated its goal of reaching a $100 million revenue run rate by the end of 2027.

Globavend Holdings (NASDAQ: GVH) announced a definitive agreement to acquire a 70% equity interest in Loomi Entertainment Group for a nominal consideration of $70, marking the company’s planned expansion beyond e-commerce logistics into digital entertainment. Through the proposed acquisition, Globavend would gain access to Loomi’s Southeast Asia-focused short drama platform and AI-powered content creation capabilities, supporting its strategy to diversify into high-growth digital media and entertainment markets.

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising.

A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) announced approval for a $30 million commercial line of credit from one of Israel’s largest commercial banks to support large-scale manufacturing and deployment of its Cust2Mate smart shopping carts. Secured by company purchase orders, the non-dilutive financing is expected to accelerate fulfillment of existing orders and global deployment plans while preserving cash resources and avoiding additional equity financing.

Recent moves by the Trump administration to loosen federal limits on medical marijuana have sparked fresh conversations across the technology sector, particularly among major digital platforms evaluating the future of cannabis advertising.

This article has been disseminated on behalf of SureNano Science Ltd. and may include paid advertising.

BluSky AI (OTCID: BSAI) announced the launch of a Regulation A+ offering aimed at enabling individual and accredited investors to participate in the company’s planned expansion of its distributed AI infrastructure network, with a minimum investment of $1,000. Proceeds are intended to support development of BluSky AI’s modular AI Factory footprint across the United States, including expansion of its Neocloud compute capacity designed to serve growing demand for large-scale AI training and inference workloads.

American Fusion (OTC: AMFN) provided an update on recent strategic engagements in Washington, D.C., where the company discussed potential applications for its Texatron(TM) Fusion Engine(TM) platform across defense, infrastructure and national energy resilience initiatives. The company also outlined corporate progress, including anticipated Form 10 effectiveness, advancement of its Rule 15c2-11 quotation application, pursuit of OTCQB qualification and continued development of its 5MW Texatron pre-production unit as it advances commercialization and capital markets objectives.

NextPlat (NASDAQ: NXPL, NXPLW) reported improved first-quarter 2026 operating results as ongoing turnaround initiatives drove stronger margins and reduced losses despite lower year-over-year revenue. The company posted quarterly revenue of $9.9 million, a record gross margin of 35%, and a 42% reduction in net loss attributable to common stockholders to approximately $1.1 million, ending the quarter with $11 million in cash and no unsecured debt as management targets positive operating income in the second half of 2026.

Aditxt (NASDAQ: ADTX), a social innovation platform accelerating health innovations, announced it will implement a 1-for-27 reverse stock split of its common stock, effective at the opening of trading on the Nasdaq Capital Market on May 18, 2026. The reverse split is intended to bring the company into compliance with Nasdaq’s minimum bid price requirement, reducing outstanding common shares from approximately 13.8 million to about 510,123, with the stock continuing to trade under the symbol ADTX.

Oncotelic Therapeutics (OTCQB: OTLC) announced its featured placement in a BioMedWire editorial focused on emerging CNS drug delivery technologies addressing challenges in Alzheimer’s disease and biodefense research. The editorial highlights the company’s proprietary intranasal nose-to-brain delivery platform, designed to bypass the blood-brain barrier and enable direct therapeutic delivery to the central nervous system, reflecting growing interest in advanced drug delivery approaches for neurological treatment.

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.

Microsoft may delay or scrap one of its most prominent climate commitments, Bloomberg News reported on May 6. The goal was to match every hour of its power consumption with a clean energy purchase by 2030. Tracking clean energy purchases hour by hour rather than averaging annually made it one of the more demanding targets in the industry.

The health IT office of the Department of Health and Human Services plans to relax the existing safeguards for AI tools intended for use within the health care system. These plans have elicited mixed reactions depending on who one talks to.

The continued disruption in the Strait of Hormuz is becoming a growing threat to the global electric vehicle industry. Although the crisis is widely linked to rising oil prices, its impact now stretches much further. Important raw materials needed for EV battery production are becoming harder to transport, creating fears of supply shortages, rising manufacturing costs, and possible slowdowns in production worldwide.

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising.

Chinese authorities are implementing regulations to formalize electric vehicle battery recycling markets as informal operations have captured roughly 70% of retired battery volumes, creating safety and environmental concerns. New EV battery recycling rules would require end-of-life batteries to remain with vehicles through authorized recycling channels, rather than entering unregulated networks where small operators disassemble and resell components.

New research funded by the NIH has uncovered a link between androgens in men and brain tumors. The preclinical study found that men with low levels of testosterone tended to have shorter survival times when diagnosed with glioblastoma when compared to those that had higher levels of this male sex hormone.

This article has been disseminated on behalf of SureNano Science Ltd. and may include paid advertising.

CNS Pharmaceuticals (NASDAQ: CNSP) reported first-quarter 2026 financial results while outlining progress in its strategic transformation toward an acquisition-driven growth model focused on clinical-stage neurology and oncology assets. Following quarter end, the company strengthened its balance sheet with a $22.5 million private placement, which, together with existing cash, is expected to support operations beyond 12 months as CNS pursues asset acquisitions and explores out-licensing opportunities for its legacy glioblastoma programs.

The global demand for compute, energy, specialized chips, and data center infrastructure continues to grow at a pace that challenges traditional development timelines. What was once a steady progression in hardware and software has evolved into a race to maintain capacity, where organizations increasingly recognize that physical infrastructure is a critical limiting factor.

This article has been disseminated on behalf of Trilogy Metals Inc. and may include paid advertising.

Kairos Pharma (NYSE American: KAPA) announced it has been named a winner in the 2026 GHP Magazine Healthcare & Pharmaceutical Awards, receiving recognition as the USA leader in drug resistance development. The award highlights the company’s work in advancing cancer therapeutics designed to address treatment resistance, underscoring Kairos’ focus on extending the effectiveness of existing cancer therapies through innovative drug resistance-targeting approaches.

BOXABL and FG Merger II Corp. (NASDAQ: FGMC) announced that the U.S. Securities and Exchange Commission has declared effective the companies’ joint registration statement on Form S-4 related to their proposed business combination, marking a significant milestone in BOXABL’s path to becoming a publicly traded company. Shareholder meetings to approve the transaction are scheduled for June 9, 2026, with closing expected shortly thereafter, subject to customary conditions, after which the combined company is expected to trade on Nasdaq under the ticker symbol BXBL.

Tonix Pharmaceuticals (NASDAQ: TNXP) announced a poster presentation at ISPOR 2026 highlighting findings from a retrospective cohort study analyzing U.S. claims data from adults with fibromyalgia between April 2021 and April 2024. The presentation will feature real-world insights related to fibromyalgia treatment, following the FDA approval of TONMYA(R) in August 2025 and its subsequent U.S. commercial launch in November 2025.

This article has been disseminated on behalf of G Mining Ventures Corp. and may include paid advertising.

This article has been disseminated on behalf of New Pacific Metals Corp. and may include paid advertising.

HeartBeam (NASDAQ: BEAT) reported first-quarter 2026 operational and financial results highlighted by the launch of its initial commercial partnerships in key U.S. markets, progress in its heart attack detection and ambulatory ECG patch initiatives, and an April public offering that raised $11.5 million in gross proceeds. The company reported a first-quarter net loss of $4.7 million, improved from $5.5 million in the prior-year period, with research and development expenses declining year over year as HeartBeam continued advancing commercialization of its FDA-cleared cardiac monitoring platform and related growth initiatives.

American Fusion(TM) (OTC: AMFN), a developer of next-generation fusion energy technologies, is entering a new stage in its development efforts as the company moves beyond early prototype work and toward integrated testing of its Texatron(TM) fusion platform. The Texas-based company recently announced completion of the structural frame for its 5-megawatt Texatron(TM) pre-production unit, a milestone that management says advances the project toward full system assembly and controlled testing readiness ( https://ibn.fm/SiutU ).

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.

The cannabis industry has spent years debating what the eventual rollback of Section 280E could mean for businesses operating legally under state law. Tax professionals have largely agreed on one point: if marijuana is moved to a lower federal drug classification, any tax relief would likely apply only going forward.

Forward Industries (NASDAQ: FWDI), focused on building and managing a large-scale Solana (SOL) treasury, recently appointed Mark Brazier as its new CFO. “In his role as CFO, Brazier will oversee Forward’s financial operations, capital structure, financial reporting, capital markets activities, and more, as Forward Industries continues to operate and grow as the worlds-largest publicly traded Solana treasury company,” reads a recent article.

Wearable Devices (NASDAQ: WLDS) announced the launch of Mudra Pro, a next-generation wearable neural sensing platform designed for developers, researchers, enterprise innovation teams and technology partners building AI, XR and human-machine interaction applications. The wrist-worn platform combines synchronized electromyography, photoplethysmography and inertial measurement sensors with embedded processing, sensor fusion and low-latency Bluetooth communication to support physiological state estimation, intent decoding, behavioral analytics and rapid prototyping, with the company positioning the product as a key outcome of its ai6 Labs initiative focused on AI-native wearable computing and next-generation human-computer interaction.